Literature DB >> 10490552

Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarction.

E Straumann1, S Yoon, B Naegeli, J Frielingsdorf, A Gerber, E Schuiki, O Bertel.   

Abstract

OBJECTIVE: To investigate the feasibility, safety, and associated time delays of interhospital transfer in patients with acute myocardial infarction for primary percutaneous transluminal coronary angioplasty (PTCA). DESIGN AND PATIENTS: Prospective observational study with group comparison in a single centre. 68 consecutive patients with acute myocardial infarction transferred for primary PTCA from other hospitals (group A) were compared with 78 patients admitted directly to the referral centre (group B). MAIN OUTCOME MEASURES: Patient groups were analysed with regard to baseline characteristics, time intervals from onset of chest pain to balloon angioplasty, hospital stay, and follow up outcome.
RESULTS: Patients in group A presented with a higher rate of cardiogenic shock initially than patients in group B (25% v 6%, p = 0.01) and had been resuscitated more frequently before PTCA (22% v 5%, p = 0.01). No deaths or other serious complications occurred during interhospital transfer. Median transfer time was 63 (range 40-115) minutes for helicopter transport (median 42 (28-122) km, n = 14), and 50 (18-110) minutes by ground ambulance (median 8 (5-68) km, n = 54). The median time interval from the decision to perform coronary arteriography to balloon inflation was 96 (45-243) minutes in group A and 52 (17-214) minutes in group B (p = 0.0001). In transferred patients (group A) the transportation associated delay and the longer in-hospital median decision time (50 (10-1120) minutes in group A v 15 (0-210) minutes in group B, p = 0.002) concurred with a longer total period of ischaemia (239 (114-1307) minutes in group A v 182 (75-1025) minutes in group B, p = 0.02) since the beginning of chest pain. Success of PTCA (TIMI 3 flow in 95% of all patients), in-hospital mortality (7% v 9%, mortality for patients not in cardiogenic shock 0% v 4%), and follow up after median 235 days was similarly favourable in groups A and B, respectively. Only one hospital survivor (group A) died during follow up.
CONCLUSION: Interhospital transport for primary PTCA in high risk patients with acute myocardial infarction is safe and feasible within a reasonable period of time. Short and medium term outcome is favourable. Optimising the decision process and transport logistics may further improve outcome by reducing the total time of ischaemia.

Entities:  

Mesh:

Year:  1999        PMID: 10490552      PMCID: PMC1760280          DOI: 10.1136/hrt.82.4.415

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

Review 1.  Cardiogenic shock: a failure in reperfusion. Time for a strategic change?

Authors:  P W Serruys; I P Kay
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

2.  Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock.

Authors:  P J Kovack; M A Rasak; E R Bates; E M Ohman; R J Stomel
Journal:  J Am Coll Cardiol       Date:  1997-06       Impact factor: 24.094

3.  Helicopter transport of patients during acute myocardial infarction.

Authors:  R L Bellinger; R M Califf; D B Mark; R A Weber; P Collins; J Stone; H R Phillips; L German; R S Stack
Journal:  Am J Cardiol       Date:  1988-04-01       Impact factor: 2.778

4.  Coronary Palmaz-Schatz stent implantation in acute myocardial infarction.

Authors:  F J Neumann; H Walter; G Richardt; C Schmitt; A Schömig
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

5.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.

Authors:  C P Cannon; C H McCabe; C M Gibson; M Ghali; R F Sequeira; G R McKendall; J Breed; N B Modi; N L Fox; R P Tracy; T W Love; E Braunwald
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

6.  Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators.

Authors:  J Lefkovits; R J Ivanhoe; R M Califf; B A Bergelson; K M Anderson; G L Stoner; H F Weisman; E J Topol
Journal:  Am J Cardiol       Date:  1996-05-15       Impact factor: 2.778

7.  Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.

Authors:  R J Simes; E J Topol; D R Holmes; H D White; W R Rutsch; A Vahanian; M L Simoons; D Morris; A Betriu; R M Califf
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

8.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

Authors:  F Zijlstra; M J de Boer; J C Hoorntje; S Reiffers; J H Reiber; H Suryapranata
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

9.  Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group.

Authors:  E M Ohman; B S George; C J White; M J Kern; P A Gurbel; R J Freedman; C Lundergan; J R Hartmann; J D Talley; M J Frey
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

10.  Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.

Authors:  C Bode; R W Smalling; G Berg; C Burnett; G Lorch; J M Kalbfleisch; R Chernoff; L G Christie; R L Feldman; A A Seals; W D Weaver
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more
  3 in total

1.  Death following coronary angioplasty.

Authors:  H H Gray; K G Callum
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Assessment of Transportation by Air for Patients with Acute ST-Elevation Myocardial Infarction from Non-PCI Centers.

Authors:  Angel Liviu Trifan; Liliana Dragomir; Mihaela Anghele; Eva Maria Elkan; Sorina Munteanu; Cosmina Moscu; Valerian-Ionuț Stoian; Anca Telehuz; Monica Laura Zlati; Mihaiela Lungu; Doina Carina Voinescu; Diana Carmen Cimpoesu; Gabriela Stoleriu; Ion Sandu; Violeta Sapira
Journal:  Healthcare (Basel)       Date:  2021-03-08

3.  Does interhospital transfer improve outcome of acute myocardial infarction? A propensity score analysis from the Cardiovascular Cooperative Project.

Authors:  John M Westfall; Catarina I Kiefe; Norman W Weissman; Anthony Goudie; Robert M Centor; O Dale Williams; Jeroan J Allison
Journal:  BMC Cardiovasc Disord       Date:  2008-09-09       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.